|
ORIGINAL INVESTIGATION
Apremilast in Recalcitrant Cutaneous Dermatomyositis: A Nonrandomized Controlled Trial
Carole Bitar, MD; Thien Ninh, MD; Katherine Brag, MD; et al.
Lifetime Sunburn Trajectories and Associated Risks of Cutaneous Melanoma and Squamous Cell Carcinoma Among a Cohort of Norwegian Women
Simon Lergenmuller, PhD; Corina S. Rueegg, PhD; Flavie Perrier, PhD; et al.
Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit
Cynthia X. Wang, MD, MPHS; Joanna L. Buss, MS; Matthew Keller, MS; et al.
Audio Author Interview: Dermatologic Follow-up vs Emergency Department Return Among Patients With Hidradenitis Suppurativa
Cost-effectiveness of Response-Adapted De-escalation of Immunotherapy in Advanced Melanoma
Zachary Cartun, MD; Wolfgang G. Kunz, MD, MHBA; Lucie Heinzerling, MD, PhD; et al.
Association of Apremilast With Vascular Inflammation and Cardiometabolic Function in Patients With Psoriasis: The VIP-A Phase 4, Open-label, Nonrandomized Clinical Trial
Joel M. Gelfand, MD, MSCE; Daniel B. Shin, PhD; April W. Armstrong, MD, MPH; et al.
BRIEF REPORT
Evaluation of Hidradenitis Suppurativa Diagnostic Criteria in Pediatric Patients
Nicole W. Kittler, MD; Jazzmin C. Williams, BS; Margaret V. Kudlinski, BS; et al.
Association of Serum Dupilumab Levels at 16 Weeks With Treatment Response and Adverse Effects in Patients With Atopic Dermatitis: A Prospective Clinical Cohort Study From the BioDay Registry
Lotte S. Spekhorst, MD; Marlies de Graaf, MD, PhD; Floris Loeff, PhD; et al.
REVIEW
Use of Patient-Reported Outcomes in Acne Vulgaris and Rosacea Clinical Trials From 2011 to 2021: A Systematic Review
Sophia Ly, BA; John Miller, BA; Lauren Tong, MLIS; et al.
Earn CME credit
CONSENSUS STATEMENT
Measuring Atopic Eczema Control and Itch Intensity in Clinical Practice: A Consensus Statement From the Harmonising Outcome Measures for Eczema in Clinical Practice (HOME-CP) Initiative
Yael A. Leshem, MD, MCR; Joanne R. Chalmers, PhD; Christian Apfelbacher, PhD; et al.
Earn CME credit
JAMA DERMATOLOGY CLINICAL EVIDENCE SYNOPSIS
Systemic Interventions for Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Summary of a Cochrane Review
Megan H. Noe, MD, MPH, MSCE; Robert G. Micheletti, MD
IMAGES IN DERMATOLOGY
Hunter Syndrome
Piyush Kumar, MD; Pratap C. Das, MD; Anupam Das, MD
Earn CME credit
Tinea Nigra Palmaris
Neerja Saraswat, MD, DNB; Durga Madhab Tripathy, MD, DNB; Sushil Kumar, MD
Earn CME credit
JAMA DERMATOLOGY CLINICOPATHOLOGICAL CHALLENGE
Multiple Yellowish Plaques in a Cobblestone Pattern on the Tongue
Eduardo Rozas-Muñoz, MD; Oscar Venegas-Rebolledo, DDS, OMFS; Juan-Andres Madariaga, MD
Earn CME credit
Indurated Plaque With Ulceration on the Dorsum of the Left Hand
Juanjuan Li, MS; Xiaomo Wu, PhD; Borui Chen, MD, PhD
Earn CME credit
JAMA DERMATOLOGY PATIENT PAGE
Sarcoidosis of the Skin
Sotonye Imadojemu, MD, MBE; Misha Rosenbach, MD
RESEARCH LETTER
Predicting DRESS Syndrome Recurrence—The ReDRESS Score
Ajay N. Sharma, MD, MBA; Kenneth Murphy, PhD; Samantha Shwe, BS; et al.
State Medicaid Coverage of Human Papillomavirus Vaccination in Adults and Implications for Dermatologists
Nathaniel Goldman, BA; Christy Nwankwo, BA; Alexandra P. Charrow, MD; et al.
Risk Factors for Vancomycin Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome
Kimberly G. Blumenthal, MD, MSc; Santiago Alvarez-Arango, MD; Xiaoqing Fu, MS; et al.
Validation of Case Identification for Melasma Using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision Codes
Nicholas Theodosakis, MD, PhD; Jaewon Yoon, BA; Katherine Young, BS, MEng; et al.
OBSERVATION
Anakinra-Associated Amyloidosis
Sara Alehashemi, MD, MPH; Surendra Dasari, PhD; Adriana A. de Jesus, MD, PhD; et al.
Recognizing Minimal Cutaneous Involvement or Systemic Symptoms in Monkeypox
Rachel Eisenstadt, MD; Walter J. Liszewski, MD; Cuong V. Nguyen, MD
AUDIO
Audio Author Interview
Dermatologic Follow-up vs Emergency Department Return Among Patients With Hidradenitis Suppurativa
COMMENT & RESPONSE
SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma
Päivi M. Ojala, PhD; Mathias Francoís, PhD
SOX18 Targeting as a Potential, Viable Therapeutic Avenue for Kaposi Sarcoma—Reply
Rafael Salido-Vallejo, MD, PhD; Agustín España, MD, PhD
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants
Peter A. Young, MPAS; Cynthia F. Griffith, MPAS; Rebecca Vasquez, MD
Geographic Distribution and Workforce Diversity of Dermatology Physician Assistants—Reply
Justin D. Arnold, MD, MMSc; Andrzej Kozikowski, PhD
CORRECTION
Errors in Figure 2
JAMA DERMATOLOGY MASTHEAD
JAMA Dermatology
|
